Review Kuenyoul Park1, Heungsup Sung2 1Department of Laboratory Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea2Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Correspondence to Heungsup Sung E-mail: sung@amc.seoul.kr Ann Clin Microbiol 2026;29(3):10. https://doi.org/10.5145/ACM.2026.29.3.10Received on 28 April 2026, Revised on 21 May 2026, Accepted on 26 May 2026, Published on 22 June 2026.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Mycoplasma pneumoniae is a leading atypical cause of community-acquired pneumonia in children and adults, and the prevalence of resistance to macrolides, the recommended first-line agents, varies markedly by region. Since the fastidious growth of M. pneumoniae makes phenotypic antimicrobial susceptibility testing impractical for routine use, clinical microbiology laboratories have focused on 23S rRNA gene-targeted molecular detection. This mini-review examines

Original article Yeon Chan Choi1*, Eun-Young Kim1*, Hyun Jin Choi1, Si Hyun Kim2, Eunkyoung You1, Ja Young Lee1, Jihyun Cho3, Seok Hoon Jeong4, Dokyun Kim4, Hyun Soo Kim5, Soo Hyun Kim6, Young Ah Kim7, Young Ree Kim8, Nam Hee Ryoo9, Jong Hee Shin10, Kyeong Seob Shin11, Young Uh12, Jeong Hwan Shin1 1Department of Laboratory Medicine and Paik Institute for Clinical Research, Inje University College of Medicine, Busan, Korea2Department of Biomedical Laboratory Science, Inje University, Gimhae, Korea3Department of Laboratory Medicine, Wonkwang University Medical School, Iksan, Korea4Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea5Department of Laboratory Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea6Department of Microbiology and Laboratory Medicine, Chonnam National University Medical School, Gwangju, Korea7Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea8Department of Laboratory Medicine, Jeju National University College of Medicine, Jeju,

Original article Jung-ah Kim1*, Sae Am Song2*, Sunjoo Kim3, Sunggyun Park4, Kwangsook Woo5, Yu Kyung Kim6 1Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea2Department of Laboratory Medicine, Inje University College of Medicine, Busan, Korea3Department of Laboratory Medicine, Gyeongsang National University College of Medicine, Jinju, Korea.4Departments of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea5Department of Laboratory Medicine, Dong-A University College of Medicine, Busan, Korea6Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Korea *These authors contributed equally to this work. Correspondence to Sunjoo Kim, E-mail: sjkim8239@hanmail.net Ann Clin Microbiol 2025;28(2):10. https://doi.org/10.5145/ACM.2025.28.2.4Received on 30 May 2025, Revised on 12 June 2025, Accepted on 12 June 2025, Published on 27 June 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Background: Bacterial antimicrobial resistance (AMR) is a major

Original article Younjee Hwang1,2*, Ju Yeong Kim1,3*, Se Il Kim4,5, Ji Yeon Sung1,6, Hye Su Moon1, Tai-Soon Yong3, Ki Ho Hong1, Hyukmin Lee1, Dongeun Yong1 1Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea2Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea3Department of Tropical Medicine, Institute of Tropical Medicine and Arthropods of Medical Importance Resource Bank, Yonsei University College of Medicine, Seoul, Korea4Division of Chemical and Medical Metrology, Center for Bioanalysis, Korea Research Institute of Standards and Science, Daejeon, Korea5Convergent Research Center for Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, Korea6Roche Diagnostics Korea, Seoul, Korea*These authors contributed equally to this work. Correspondence to Dongeun Yong, E-mail: deyong@yuhs.ac Ann Clin Microbiol 2025;28(1):3. https://doi.org/10.5145/ACM.2025.28.1.3Received on 31 December 2024, Revised on 6 March 2025, Accepted on 10 March 2025, Published on 20 March 2025.Copyright © Korean

Review article Jong-Yil Chai1, Woon-Mok Sohn2, Bong-Kwang Jung3 1Department of Tropical Medicine and Parasitology, Seoul National University College of Medicine, Seoul2Department of Parasitology and Tropical Medicine, Gyeongsang National University College of Medicine, Jinju;3MediCheck Research Institute, Korea Association of Health Promotion, Seoul, Korea Corresponding to Jong-Yil Chai, E-mail: cjy@snu.ac.kr Ann Clin Microbiol 2024;27(2):93-130. https://doi.org/10.5145/ACM.2024.27.2.6Received on 3 April 2024, Revised on 23 April 2024, Accepted on 29 April 2024, Published on 20 June 2024.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Human anisakiasis (or anisakidosis) is a disease caused by the ingestion of marine fish or cephalopods infected with anisakid nematode larvae of the genera Anisakis, Pseudoterranova, Contracaecum, and Hysterothylacium. Anisakiasis is a clinically important disease that often manifests as an acute abdominal syndrome requiring emergency medical attention and care. In Korea, at